Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_assertion type Assertion NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_head.
- NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_assertion description "[The data provide further evidence that targeted inhibition of MEK may be therapeutically effective for thyroid cancer, particularly if the PI3K and NF-kappaB pathways are concurrently inhibited.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_provenance.
- NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_assertion evidence source_evidence_literature NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_provenance.
- NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_assertion SIO_000772 18651802 NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_provenance.
- NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_assertion wasDerivedFrom befree-2016 NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_provenance.
- NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_assertion wasGeneratedBy ECO_0000203 NP684191.RAZ-WoqYq3PiBbNG_xxtiFJD5201mCFvktW5HM-vbmIMs130_provenance.